Pfizer Refuses Cooperation with DNDi on Study of Paxlovid Treatment Adapted to Low Income Countries 08/04/2022 Elaine Ruth Fletcher & Kerry Cullinan Pfizer has so far refused an invitation from the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) to cooperate on a study exploring whether the treatment window of its successful antiviral drug, Paxlovid, could be extended from 5-7 days using another drug compound in addition, Dr Nathalie Strub-Wourgaft, Director of DNDi’s COVID-19 Response, told Health Policy […] Continue reading -> WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> WHO Urges Caution on Africa’s Rollback of COVID-19 Measures 24/03/2022 Paul Adepoju Even while other parts of the world see upticks, or in the case of Asia, huge spikes in COVID-19 cases, an increasing number of African countries are scaling back COVID-19 surveillance and quarantine measures – a trend that the World Health Organization finds worrisome in the continent that still has the lowest rates of vaccination […] Continue reading -> Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO European Regional Director Visits Lviv, Ukraine; Reaffirms Support for Rebuilding Health System 07/04/2022 Raisa Santos In a highly symbolic visit to Lviv, Ukraine, World Health Organization Regional Director Hans Kluge reaffirmed WHO’s commitment to rebuilding the country’s war-torn health system. Speaking in a press briefing staged directly from Lviv, Kluge said, “We are committed to work through a decentralized footprint [in Ukraine], both during the current humanitarian response but also […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> WHO Urges Caution on Africa’s Rollback of COVID-19 Measures 24/03/2022 Paul Adepoju Even while other parts of the world see upticks, or in the case of Asia, huge spikes in COVID-19 cases, an increasing number of African countries are scaling back COVID-19 surveillance and quarantine measures – a trend that the World Health Organization finds worrisome in the continent that still has the lowest rates of vaccination […] Continue reading -> Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> WHO Urges Caution on Africa’s Rollback of COVID-19 Measures 24/03/2022 Paul Adepoju Even while other parts of the world see upticks, or in the case of Asia, huge spikes in COVID-19 cases, an increasing number of African countries are scaling back COVID-19 surveillance and quarantine measures – a trend that the World Health Organization finds worrisome in the continent that still has the lowest rates of vaccination […] Continue reading -> Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Urges Caution on Africa’s Rollback of COVID-19 Measures 24/03/2022 Paul Adepoju Even while other parts of the world see upticks, or in the case of Asia, huge spikes in COVID-19 cases, an increasing number of African countries are scaling back COVID-19 surveillance and quarantine measures – a trend that the World Health Organization finds worrisome in the continent that still has the lowest rates of vaccination […] Continue reading -> Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mass Polio Vaccination Drive to Administer More Than 80 Million Doses to Southern African Children in Five Countries 18/03/2022 Raisa Santos Malawi is launching a mass vaccination campaign against wild poliovirus type 1, which is to extend to 23 million children across five southern African countries, WHO said on Friday. The campaign, to kick off Sunday, follows Malawi’s declaration of a polio outbreak on 17 February – three months after the first polio virus case in […] Continue reading -> Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Paxlovid Goes Generic in 95 Countries – Too Little, Too Late, say Access Advocates 17/03/2022 Elaine Ruth Fletcher A Medicines Patent Pool (MPP) announcement Thursday that it has signed agreements with 35 companies to manufacture generic versions of Pfizer’s life-saving COVID-19 Paxlovid treatment for distribution in 95 low- and middle-income countries came fire almost immediately from medicines access groups as too little, too late. The MPP-brokered sublicences follow on from an agreement between […] Continue reading -> WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Welcomes US Move to Share COVID-19 Technologies with C-TAP Patent Pool 04/03/2022 Raisa Santos The United States National Institutes of Health (NIH) will offer certain government-funded coronavirus technologies to WHO’s COVID-19 Technology Access Pool (C-TAP), top US officials said on Thursday. The announcement by US Secretary of Health and Human Services Xavier Becerra at a virtual meeting Thursday with other ministers of health, could help bolster support for the […] Continue reading -> Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Molnupiravir Joins WHO’s Recommended COVID-19 Treatment List 03/03/2022 Editorial team Molnupiravir, an oral COVID-19 antiviral medication, has just been added as a conditional recommendation to the World Health Organization’s living guidelines on COVID-19 therapeutics. The pill, created by Merck, had already been approved by the Medicines Patent Pool (MPP) in January to be distributed and supplied in 105 low- and middle-income countries (LMICs). In comparison […] Continue reading -> Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eliminating Viral Hepatitis in Europe is Possible – Soon 25/02/2022 Maria Buti Somewhere between 10 and 14 million people are living with viral hepatitis B (HBV) or hepatitis C (HCV) in WHO’s European region alone. And over three quarters of those people do not even know they have either disease. It’s no surprise then, that approximately 300 people die each day due to HBV and HCV -related […] Continue reading -> Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Africa Marks One Year Since Beginning of COVID Vaccine Rollout – its Largest-Ever 24/02/2022 Paul Adepoju Within one year, Africa has gone from waiting for its first COVID-19 vaccine shipment from the WHO-supported global COVAX facility to having excess doses available that some countries are struggling roll out efficiently. Reflections on the first anniversary of the massive COVAX vaccine rollout. On 24 February 2021, Health Policy Watch reported the global COVAX […] Continue reading -> Posts navigation Older postsNewer posts